Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C
Clinical trial NCT00695019 · COMPLETED
Trial details
- NCT number
- NCT00695019
- Sponsor
- Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-11-01
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.